Btcorp Generique Nano Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.23 Cr
as on 12-12-2024
- Revenue -85.41%
(FY 2021)
- Profit -112.92%
(FY 2021)
- Ebitda -108.29%
(FY 2021)
- Net Worth -9.86%
(FY 2021)
- Total Assets 12.31%
(FY 2021)
About Btcorp Generique Nano
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.23 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ashma Parween and Md Ali serve as directors at the Company.
- CIN/LLPIN
U74999KA2018PTC111010
- Company No.
111010
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Btcorp Generique Nano Private Limited offer?
Btcorp Generique Nano Private Limited offers a wide range of products and services, including FRP Lining, PU & Powder Coatings, Automotive Paints and Coatings.
Who are the key members and board of directors at Btcorp Generique Nano?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Md Ali  | Managing Director | 12-Mar-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashma Parween | Director | 12-Mar-2018 | Current |
Financial Performance of Btcorp Generique Nano.
Btcorp Generique Nano Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 85.41% decrease. The company also saw a substantial fall in profitability, with a 112.92% decrease in profit. The company's net worth dipped by a decrease of 9.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Btcorp Generique Nano?
In 2021, Btcorp Generique Nano had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 19 Mar 2020 | ₹2.23 Cr | Satisfied |
How Many Employees Work at Btcorp Generique Nano?
Unlock and access historical data on people associated with Btcorp Generique Nano, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Btcorp Generique Nano, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Btcorp Generique Nano's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
